EP Patent

EP0349091A1 — Pharmaceutical composition

Assigned to Individual · Expires 1990-01-03 · 36y expired

What this patent protects

Pharmeceutical compositions having a formulation and form suitable for nasal administration, and containing 17β-oestradiol and/or progesterone. According to the invention, the composition also contains dimethyl-β-cyclodextrin.

USPTO Abstract

Pharmeceutical compositions having a formulation and form suitable for nasal administration, and containing 17β-oestradiol and/or progesterone. According to the invention, the composition also contains dimethyl-β-cyclodextrin.

Drugs covered by this patent

Androgel (TESTOSTERONE) · Besins Hlthcare

Patent Metadata

Patent number: EP0349091A1
Jurisdiction: EP
Classification: —
Expires: 1990-01-03
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.